Surgery Websites
Department of Surgery »  Faculty »  Emeritus Faculty »  Stephen J. Tomlanovich, M.D.
Stephen J. Tomlanovich, M.D.

Stephen J. Tomlanovich, M.D.

Emeritus Professor of Medicine and Surgery
Departments of Medicine and Surgery
Medical Director, Kidney Transplant Service

Contact Information

Academic Office
(415) 353-8390
Fax: 415.353.8974
Open Popup
  • Notre Dame University, BS
  • University of Michigan Medical School, MD
  • Rush-Presbyterian-St. Luke's Medical Center, Internal Medicine
  • Henry Ford Hospital, Internal Medicine
  • Stanford University Medical Center, Nephrology
  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Nephrology - Subspecialty
  • Chronic Kidney Disease
  • End Stage Renal Disease (Kidney Failure)
  • Kidney Transplantation
  • Living Kidney Donor Transplantation
  • Pancreas Transplantation
  • Transplant Nephrology


Dr. Stephen Tomlanovich is a nationally known kidney transplant specialist who has worked to improve patient access to transplants through the development of outreach clinics in communities throughout Northern California.

In addition to caring for patients, he conducts research to help develop new immunosuppressive medications to prevent organ rejection. He is a principal investigator in numerous studies that have led to new immunosuppressive drugs to improve the success rate of transplants while minimizing side effects. He also is involved with regional and national organizations and serves on the board of directors of the California Transplant Donor Network and the Transpacific Renal Network.

Tomlanovich earned a medical degree at the University of Michigan and completed an internship at Rush Presbyterian-St. Luke's Hospital followed by a residency at Henry Ford Hospital in Detroit. In 1985, he completed a nephrology fellowship at Stanford University and joined UCSF Medical Center.

Most recent publications from a total of 25
  1. Qazi Y, Shaffer D, Kaplan B, Kim DY, Luan FL, Peddi VR, Shihab F, Tomlanovich S, Yilmaz S, McCague K, Patel D, Mulgaonkar S. Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data. Am J Transplant. 2017 May; 17(5):1358-1369. View in PubMed
  2. O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB. The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant. 2014 Apr; 14(4):779-87. View in PubMed
  3. Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012 Dec 15; 94(11):1117-23. View in PubMed
  4. Chandran S, Baxter-Lowe L, Olson JL, Tomlanovich SJ, Webber A. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report. Transplant Proc. 2011 Jun; 43(5):2097-101. View in PubMed
  5. Findlay JY, Fix OK, Paugam-Burtz C, Liu L, Sood P, Tomlanovich SJ, Emond J. Critical care of the end-stage liver disease patient awaiting liver transplantation. Liver Transpl. 2011 May; 17(5):496-510. View in PubMed
  6. Odisho AY, Freise CE, Tomlanovich SJ, Vagefi PA. Inguinal herniation of a transplant ureter. Kidney Int. 2010 Jul; 78(1):115. View in PubMed
  7. Woodle ES, Peddi VR, Tomlanovich S, Mulgaonkar S, Kuo PC. A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):73-83. View in PubMed
  8. Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1230-8. View in PubMed
  9. Bolin P, Tanriover B, Zibari GB, Lynn ML, Pirsch JD, Chan L, Cooper M, Langone AJ, Tomlanovich SJ. Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients. Transplantation. 2007 Dec 15; 84(11):1443-51. View in PubMed
  10. Tomlanovich SJ, Vincenti F. Sirolimus: defining nephrotoxicity in the renal transplant recipient. Clin J Am Soc Nephrol. 2007 Mar; 2(2):198-9. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Stephen J. Tomlanovich, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.


Site Directory